1. Contrast-Induced Nephropathy in patients submitted to percutaneous coronary intervention: an integrative review
- Author
-
Cassiane Dezoti da Fonseca, Angélica Gonçalves Silva Belasco, Matheus Santos Moitinho, Dulce Aparecida Barbosa, Adriano Caixeta, and Eduesley Santana Santos
- Subjects
Male ,medicine.medical_specialty ,Statin ,medicine.drug_class ,medicine.medical_treatment ,RT1-120 ,030232 urology & nephrology ,Contrast-induced nephropathy ,Contrast Media ,Nursing ,Review ,030204 cardiovascular system & hematology ,Nephropathy ,03 medical and health sciences ,Percutaneous Coronary Intervention ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,General Nursing ,business.industry ,Incidence ,Incidence (epidemiology) ,Percutaneous coronary intervention ,Acute Kidney Injury ,Ascorbic acid ,medicine.disease ,Clinical trial ,Sodium Bicarbonate ,Balloon Coronary Angioplasty ,Kidney Diseases ,business - Abstract
Objective: to demonstrate scientific evidence on incidence and factors associated with contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Methods: an integrative review carried out in the VHL, PubMed, VHL Regional Portal and SciELO databases, of articles published between 2014 and 2019. Results: the sample consisted of five original articles, two cohorts, two control cases and a clinical trial. The incidence of contrast-induced nephropathy ranged from 6% to 24%. It stands out among patients with advanced age, male gender, diabetes mellitus, systemic arterial hypertension, volume of contrast infused and osmolarity. Intravenous hydration, sodium bicarbonate, ascorbic acid and statin were important prophylactic agents. Conclusion: this study envisioned the main risk factors for contrast-induced nephropathy in patients undergoing percutaneous coronary intervention and elucidated preventive measures that guide multidisciplinary health care aiming at a quality and safe care.
- Published
- 2020
- Full Text
- View/download PDF